H-CYTE: H-CYTE Announces 1-for-1,000 Reverse Stock SplitStrategic Decision to Support Improved Investor Profile and Potential Future Uplisting of Securities to Major Exchange

H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, today announced that the Board approved a 1-for-1,000 reverse stock split, effective 9:30 a.m. on Monday, June 13, 2022.